Video-Assisted Left Atrial Appendage Exclusion Trial
NCT02226133 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2015-05-05
Summary
Exclusion of the LAA(Left Atrial Appendage) using the TigerPaw II System with VATS technique is safe and effective.
Conditions
- Heart Diseases
Interventions
- DEVICE
-
LAAx, Inc. TigerPaw® System II
Exclusion of Left Atrial Appendage.
Sponsors & Collaborators
-
LAAx, Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2015-09-30
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
VCLIP Post-Market Study, Long-term Follow-up on LAA Exclusion Using AtriClip
NCT05101993 ·Status: COMPLETED ·Phase: NA
-
Coherex WAVECREST I Left Atrial Appendage Occlusion Study
NCT02239887 ·Status: COMPLETED
-
Left Atrial Appendage Closure With WATCHMAN FLX Device in Recurrent Gastrointestinal Bleeding: The GI-FLX Registry
NCT06052358 ·Status: TERMINATED
-
AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)
NCT02701062 ·Status: COMPLETED ·Phase: PHASE4
-
Applause Study I - Append System Early Feasibility Study
NCT07278869 ·Status: RECRUITING ·Phase: NA
-
Left Atrial Appendage Exclusion Study
NCT01983605 ·Status: COMPLETED ·Phase: NA
-
Reduction in Arrhythmia Burden With Left Atrial Posterior Wall Ablation for Persistent AF
NCT05195268 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Effectiveness of Left Atrial Appendage Occlusion
NCT00567515 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy
NCT01182441 ·Status: COMPLETED ·Phase: PHASE3
-
Left Atrial Appendage Ligation Using the Atriclip Device
NCT03759418 ·Status: COMPLETED
-
Safety and Performance of ENDOMATIC SEPIOLA Left Atrial Appendage (LAA) Closure Device
NCT06099106 ·Status: RECRUITING ·Phase: NA
-
An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation
NCT05565599 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
NCT02702271 ·Status: COMPLETED ·Phase: NA
-
Amulet™ ADVANCE LAA
NCT05997446 ·Status: ACTIVE_NOT_RECRUITING
-
Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia
NCT02130765 ·Status: TERMINATED ·Phase: NA
-
BoxX-NoAF Clinical Trial
NCT06989775 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure
NCT03088072 ·Status: UNKNOWN ·Phase: PHASE4
-
Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF
NCT04684212 ·Status: WITHDRAWN ·Phase: NA
-
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
NCT03732794 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation
NCT02928497 ·Status: COMPLETED ·Phase: NA
-
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
NCT03463317 ·Status: COMPLETED ·Phase: PHASE4
-
RF Applications for Residual LAA Leaks
NCT04726943 ·Status: UNKNOWN ·Phase: NA
-
Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation
NCT01362738 ·Status: COMPLETED ·Phase: PHASE3
-
AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB
NCT00571779 ·Status: WITHDRAWN ·Phase: PHASE2
-
Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy
NCT04676880 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA